118 related articles for article (PubMed ID: 33412313)
1. Comprehensive serum proteomic analysis in early endometrial cancer.
Uyar DS; Huang YW; Chesnik MA; Doan NB; Mirza SP
J Proteomics; 2021 Mar; 234():104099. PubMed ID: 33412313
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of malignant and benign endometrium according to obesity and insulin-resistance status using Reverse Phase Protein Array.
Raglan O; Assi N; Nautiyal J; Lu H; Gabra H; Gunter MJ; Kyrgiou M
Transl Res; 2020 Apr; 218():57-72. PubMed ID: 31954096
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of FAM83D gene expression across human cancer types.
Walian PJ; Hang B; Mao JH
Oncotarget; 2016 Jan; 7(3):3332-40. PubMed ID: 26678035
[TBL] [Abstract][Full Text] [Related]
4. Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.
Bateman NW; Teng PN; Hope E; Hood BL; Oliver J; Ao W; Zhou M; Wang G; Tommarello D; Wilson K; Litzy T; Conrads KA; Hamilton CA; Darcy KM; Casablanca Y; Maxwell GL; Bae-Jump V; Conrads TP
Cancer Med; 2020 Feb; 9(3):1092-1103. PubMed ID: 31808620
[TBL] [Abstract][Full Text] [Related]
5. FAM83D is associated with gender, AJCC stage, overall survival and disease-free survival in hepatocellular carcinoma.
Liu X; Gao H; Zhang J; Xue D
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910840
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer and single-cell analysis reveals
Yu H; Chen Q; Wang Z; Qian X; Pan Y
Front Genet; 2022; 13():1009325. PubMed ID: 36568373
[No Abstract] [Full Text] [Related]
7. Gel-Based Proteomic Identification of Suprabasin as a Potential New Candidate Biomarker in Endometrial Cancer.
Celsi F; Monasta L; Arrigoni G; Battisti I; Licastro D; Aloisio M; Di Lorenzo G; Romano F; Ricci G; Ura B
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216190
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the proteomic signature of human endometrial receptivity.
Garrido-Gómez T; Quiñonero A; Antúnez O; Díaz-Gimeno P; Bellver J; Simón C; Domínguez F
Hum Reprod; 2014 Sep; 29(9):1957-67. PubMed ID: 25106620
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of FAM83D promotes malignant phenotypes of lung adenocarcinoma by regulating cell cycle.
Shi R; Sun J; Sun Q; Zhang Q; Xia W; Dong G; Wang A; Jiang F; Xu L
Am J Cancer Res; 2016; 6(11):2587-2598. PubMed ID: 27904773
[TBL] [Abstract][Full Text] [Related]
10. Differential proteomic analysis of endometrial fluid suggests increased inflammation and impaired glucose metabolism in non-implantative IVF cycles and pinpoints PYGB as a putative implantation marker.
Azkargorta M; Escobes I; Iloro I; Osinalde N; Corral B; Ibañez-Perez J; Exposito A; Prieto B; Elortza F; Matorras R
Hum Reprod; 2018 Oct; 33(10):1898-1906. PubMed ID: 30169642
[TBL] [Abstract][Full Text] [Related]
11. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
Zhu H; Diao S; Lim V; Hu L; Hu J
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
[TBL] [Abstract][Full Text] [Related]
12. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
13. Advances in endometrial cancer protein biomarkers for use in the clinic.
Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
[TBL] [Abstract][Full Text] [Related]
14. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
Yan L; Yao J; Qiu J
Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
16. YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 Pathway.
Zhao T; Wang M; Zhao X; Weng S; Qian K; Shi K; Gu Y; Ying W; Qian X; Zhang Y
Front Oncol; 2022; 12():763341. PubMed ID: 35186724
[TBL] [Abstract][Full Text] [Related]
17. Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discovery.
Njoku K; Pierce A; Chiasserini D; Geary B; Campbell AE; Kelsall J; Reed R; Geifman N; Whetton AD; Crosbie EJ
EBioMedicine; 2024 Apr; 102():105064. PubMed ID: 38513301
[TBL] [Abstract][Full Text] [Related]
18. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
19. FAM83D activates the MEK/ERK signaling pathway and promotes cell proliferation in hepatocellular carcinoma.
Wang D; Han S; Peng R; Wang X; Yang XX; Yang RJ; Jiao CY; Ding D; Ji GW; Li XC
Biochem Biophys Res Commun; 2015 Mar; 458(2):313-20. PubMed ID: 25646692
[TBL] [Abstract][Full Text] [Related]
20. Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women.
Njoku K; Pierce A; Geary B; Campbell AE; Kelsall J; Reed R; Armit A; Da Sylva R; Zhang L; Agnew H; Baricevic-Jones I; Chiasserini D; Whetton AD; Crosbie EJ
Br J Cancer; 2023 May; 128(9):1723-1732. PubMed ID: 36807337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
